Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15797239rdf:typepubmed:Citationlld:pubmed
pubmed-article:15797239lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:15797239lifeskim:mentionsumls-concept:C0205103lld:lifeskim
pubmed-article:15797239lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:15797239lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:15797239lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:15797239lifeskim:mentionsumls-concept:C0644298lld:lifeskim
pubmed-article:15797239pubmed:issue2lld:pubmed
pubmed-article:15797239pubmed:dateCreated2005-3-30lld:pubmed
pubmed-article:15797239pubmed:abstractTextThe inactivation of cytochrome P450 enzymes by cyclopropylamines has been attributed to a mechanism involving initial one-electron oxidation at nitrogen followed by scission of the cyclopropane ring leading to covalent modification of the enzyme. Herein, we report that in liver microsomes N-cyclopropylbenzylamine (1) and related compounds inactivate P450 to a large extent via formation of metabolic intermediate complexes (MICs) in which a nitroso metabolite coordinates tightly to the heme iron, thereby preventing turnover. MIC formation from 1 does not occur in reconstituted P450 systems with CYP2B1/2, 2C11 or 2E1, or in microsomes exposed to gentle heating to inactivate the flavin-containing monooxygenase (FMO). In contrast, N-hydroxy-N-cyclopropylbenzylamine (3) and N-benzylhydroxylamine (4) generate MICs much faster than 1 in both reconstituted and microsomal systems. MIC formation from nitrone 5 (PhCH = N(O)cPr) is somewhat faster than from 1, but very much faster than the hydrolysis of 5 to a primary hydroxylamine. Thus the major overall route from 1 to a P450 MIC complex would appear to involve FMO oxidation to 3, further oxidation by P450 and/or FMO to nitrone 5' (C2H4C = N(O)CH2Ph), hydrolysis to 4, and P450 oxidation to alpha-nitrosotoluene as the precursor to oxime 2 and the major MIC from 1.lld:pubmed
pubmed-article:15797239pubmed:languageenglld:pubmed
pubmed-article:15797239pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:citationSubsetIMlld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15797239pubmed:statusMEDLINElld:pubmed
pubmed-article:15797239pubmed:monthAprlld:pubmed
pubmed-article:15797239pubmed:issn0003-9861lld:pubmed
pubmed-article:15797239pubmed:authorpubmed-author:HanzlikRobert...lld:pubmed
pubmed-article:15797239pubmed:authorpubmed-author:CernyMatthew...lld:pubmed
pubmed-article:15797239pubmed:issnTypePrintlld:pubmed
pubmed-article:15797239pubmed:day15lld:pubmed
pubmed-article:15797239pubmed:volume436lld:pubmed
pubmed-article:15797239pubmed:ownerNLMlld:pubmed
pubmed-article:15797239pubmed:authorsCompleteYlld:pubmed
pubmed-article:15797239pubmed:pagination265-75lld:pubmed
pubmed-article:15797239pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:meshHeadingpubmed-meshheading:15797239...lld:pubmed
pubmed-article:15797239pubmed:year2005lld:pubmed
pubmed-article:15797239pubmed:articleTitleCyclopropylamine inactivation of cytochromes P450: role of metabolic intermediate complexes.lld:pubmed
pubmed-article:15797239pubmed:affiliationDepartment of Medicinal Chemistry, University of Kansas, Lawrence, KS, USA.lld:pubmed
pubmed-article:15797239pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15797239pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15797239lld:pubmed